Evidence map›Paper›PMID 39728267›Full record

ReviewJournal of cardiovascular development and disease2024

Effect of Coenzyme Q10 Supplementation on Lipid and Glycaemic Profiles: An Umbrella Review.

Silvana Patiño-Cardona, Miriam Garrido-Miguel, Carlos Pascual-Morena, Carlos Berlanga-Macías, Maribel Lucerón-Lucas-Torres, Sofía Alfaro-González, Irene Martínez-García

Abstract readReview
In one paragraph

Review in Journal of cardiovascular development and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Optimized CoQ10 deliveryRSC advances · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Silvana Patiño-CardonaHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.
Miriam Garrido-MiguelHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0003-4617-616X
Carlos Pascual-MorenaHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0003-1154-8752
Carlos Berlanga-MacíasHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0003-3998-8039
Maribel Lucerón-Lucas-TorresHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0002-7944-1065
Sofía Alfaro-GonzálezHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0001-9726-8377
Irene Martínez-GarcíaCarVasCare Research Group (2023-GRIN-34459), Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, 16001 Cuenca, Spain.ORCID 0000-0001-7835-6953

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coenzyme Q10 (CoQ10) has been suggested as an adjunct therapy for endocrine and metabolic disorders. The aim of this study was to synthesise the evidence for the effect of CoQ10 supplementation on lipid and/or glycaemic alterations, including total cholesterol (TC), LDL- and HDL-cholesterol (LDL-C and HDL-C), lipoprotein a, fasting blood glucose (FBG), haemoglobin A1c (HbA1c), fasting insulin and Homeostatic Model Assessment of Insulin Resistance. A systematic search was conducted in Medline, Scopus, Web of Science and the Cochrane Library from their inception to July 2024. Meta-analyses that evaluated the effect of CoQ10 on the lipid or glycaemic profiles were included. Results were expressed as mean difference (MD) or standardised mean difference (SMD). CoQ10 showed an effect on the glycaemic profile, especially on FBG (MD from -11.21 to -5.2 mg/dL, SMD from -2.04 to -0.17) and on HbA1c (MD from -1.83 to -0.12%, SMD of -0.30). CoQ10 may also have an effect on the lipid profile, such as TC, triglycerides, HDL-C and even LDL-C, although the inconsistency of the results was somewhat higher. Supplementation with CoQ10 may be beneficial, especially in populations with diabetes mellitus or other endocrine and metabolic disorders. It could also have some effect on lipid parameters, which, together with the above, may reduce cardiovascular morbidity and mortality, although this is something that needs further research.

Indexed as

cardiovascular riskglycaemic profilelipid profilemeta-analysisnutraceuticalsystematic review

Identifiers

PMID39728267
PMCPMC11678712

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.